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Compartment syndrome is a unique form of ischaemia of skeletal muscle which occurs 
despite patency of the large vessels. Decompression allows the influx of activated 
leucocytes which cause further injury. Vitamin C is a powerful antioxidant which 
concentrates preferentially in leucocytes and attenuates reperfusion-induced muscle injury. 
We have evaluated the use of pretreatment with oral vitamin C in the prevention of injury 
caused by compartment syndrome in a rat cremasteric muscle model.
Acute and delayed effects of pretreatment with vitamin C were assessed at one and 24 
hours after decompression of compartment syndrome. Muscle function was assessed 
electrophysiologically. Vascular, cellular and tissue inflammation was assessed by staining 
of intercellular adhesion molecule-1 (ICAM-1) and by determination of the activity of 
myeloperoxidase (MPO) in neutrophils and tissue oedema.
Compartment syndrome impaired skeletal muscle function and increased the expression 
of ICAM-1, activity of MPO and muscle weight increased significantly. Pretreatment with 
vitamin C preserved muscle function and reduced the expression of ICAM-1, infiltration of 
the neutrophils and oedema.
Compartment syndrome is a diagnostic and
therapeutic challenge in orthopaedic and
trauma surgery. Typical situations which lead
to compartment syndrome include crush inju-
ries and revascularisation procedures,1-3 but it
occurs most frequently after injury to the lower
limbs in young men.4 It has been reported as a
complication in up to 4% of all tibial frac-
tures,5 and surgical decompression by fasciot-
omy remains the only effective treatment. After
a fracture or a crush injury, the pressure within
the closed fascial compartment rises and is
exacerbated further by the accompanying
tissue oedema. This increase in pressure may
cause venous occlusion or microvascular shut-
down, both of which result in microvascular
hypoxia.6,7 Reperfusion results in the genera-
tion of large quantities of reactive oxygen
species in the hypoxic tissue. Endothelial adhe-
sion molecules such as intercellular adhesion
molecule-1 (ICAM-1) are upregulated and
interact with pro-inflammatory cytokines to
chemoattract circulating neutrophils.8 Although
the tissue insult generated by the ischaemia-
reperfusion process is an important compo-
nent of injury to muscle caused by compart-
ment syndrome, the amount of muscle damage
in compartment syndrome is greater than that
which occurs after an equivalent period of
ischaemia alone. This suggests that there is a
synergistic effect of increased pressure and sus-
tained microvascular hypoxia on muscle injury
in compartment syndrome.9 Vitamin C is a
powerful endogenous antioxidant which is
taken up preferentially by circulating neutro-
phils and lymphocytes.10 It has been shown to
reduce many components of neutrophil-medi-
ated tissue injury after ischaemia-reperfusion
injury. In particular, vitamin C can protect the
endothelium from direct injury by oxidants,
including H2O2, and prevent microvascular
dysfunction.11,12 We have demonstrated pre-
viously that pretreatment with oral vitamin C
reduced lung injury after reperfusion injury of
the lower torso and acute reperfusion-induced
muscle injury.13,14 We and others have also
shown that the production of oxidants in
neutrophils, a key component of neutrophil-
mediated cell toxicity in ischaemia-reperfusion
injury, is also reduced by the administration of
vitamin C.13,15,16 Our aim in this study was to
investigate whether pretreatment with oral
vitamin C reduced skeletal muscle injury
resulting from compartment syndrome.
Materials and Methods
We used 36 Sprague-Dawley rats weighing 300
to 400 g. They were randomised to receive
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either right orchidectomy only (control group), compart-
ment syndrome only or vitamin C plus compartment syn-
drome (Table I). The animals treated with vitamin C
received a dose of 2 g/kg daily (Roche Pharmaceuticals,
Dublin, Eire) for five days before injury. Daily vitamin C
was administered in 30 ml of drinking water and experi-
ments were performed only in rats which had consumed the
full five-day dose of vitamin C.
Induction of compartment syndrome. The preparation of
the cremasteric muscle was performed in halothane-anaes-
thetised rats according to our previously described proto-
col.14 The isolated cremasteric neurovascular pedicle was
introduced into the purpose-built compartment-syndrome
chamber and the portal sealed with an angioplasty catheter
(Fig. 1). The pressure in the angioplasty catheter was main-
tained at chamber pressure or below to prevent a tourni-
quet-like effect on the neurovascular pedicle. Elevation of
chamber pressure to within 10 mmHg of the diastolic blood
pressure for three hours was used to induce compartment
syndrome.6 At the end of this period the pressure was
released to simulate a fasciotomy. In the acute experiments,
after reperfusion for one hour the cremasteric muscle was
harvested. Muscle function, oedema, the expression of
ICAM-1 and the activity of myeloperoxidase (MPO) were
assessed. In the delayed groups the muscle was inspected
for viability after decompression, returned to the abdomi-
nal cavity and the scrotum was sutured using Ethilon
sutures (Johnson & Johnson, Brussels, Belgium). The rats
were resuscitated and given intramuscular analgesia with
buprenorphine (0.03 mg; Schering-Plough, Welwyn
Garden City, UK). After 24 hours, they were re-anaesthe-
tised and the cremasteric muscle was harvested for experi-
mental testing. The rats were then killed using a lethal
intracardiac dose of sodium pentobarbitone.
Assessment of muscle function. A strip of cremasteric muscle
2.5 x 0.5 cm in size from a central area was isolated. As pre-
viously described,14 the strip was maintained at 37˚C in a
bicarbonate buffer solution (Sigma Chemical Co Ltd,
Irvine, UK) and the pH was corrected from 7.3 to 7.4. The
pH and O2 saturation were maintained by constant aera-
tion with a 95%O2/5%CO2 gas mixture (BOC Gases, Dub-
lin, Eire). The muscle was stimulated using supramaximal
pulses (20 V, 2 msec square-wave duration17-19 and 40Hz)
obtained from a pulse generator (Harvard stimulator; Har-
vard Apparatus, Edenbridge, UK). The isometric contrac-
tion of each muscle strip was assessed in response to a
timed series of twitch and tetanic electrical stimuli. The
muscle strip was then weighed (Oertling YA124 Analytical
Balance; Avery Berkel, Warley, UK).
Myeloperoxidase assay. Measurement of MPO has been
shown to be a reliable method of quantitatively assessing
neutrophil sequestration.20 The activity of MPO was
assayed spectrophotometrically (450 nm, Beckton-Dickin-
son, Mountain View, California) in weighed homogenised
sections of cremasteric muscle as previously described.14
One unit of MPO was defined as that which degraded 1
µmol of H2O2 per minute at 25˚C.20
Muscle oedema. The wet-to-dry ratio is a simple assess-
ment of tissue oedema. A separate section of freshly har-
vested cremasteric muscle was weighed (Oertling YA124
Analytical Balance; Avery Berkel), and then heated at 60˚C
Table I. Details of the experimental groups and their treatment
Group Pretreatment Description procedure
Acute (3-hour assessment)
Surgical control (n = 6) None Orchidectomy alone
Compartment syndrome alone (n = 6) None Orchidectomy, 3-hour compartment 
syndrome and 1-hour reperfusion
Compartment syndrome and vitamin C (n = 6) Vitamin C 2g/kg/day for 5 days Orchidectomy, 3-hour compartment 
syndrome and 1-hour reperfusion
Delayed (24-hour assessment)
24-hour post-surgical control (n = 6) None Orchidectomy alone
24-hour post-compartment syndrome alone (n = 6) None Orchidectomy, 3-hour compartment 
syndrome and 24-hour reperfusion
24-hour post-compartment syndrome and vitamin C (n = 6) Vitamin C 2g/kg/day for 5 days Orchidectomy, 3-hour compartment 














Diagram of the chamber for the induction of compartment syndrome in
rat cremasteric muscle.
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in an oven (Gallenkamp Model IH-150; Sanyo Gallenkamp
plc, Loughborough, UK) for 72 hours until such time that
the weight had become constant. The difference between
the wet and dry weight was recorded.
ICAM-1 expression. This was assessed in the acute groups
using a standard immunocytochemical technique (StreptA-
BComplex/HRP code K377; DAKO A/S, Glostrup, Den-
mark). A section of cremasteric muscle was mounted in an
optimal cutting temperature compound (Tissue-Tek; Miles
Laboratories, Elkhart, Indiana) and snap-frozen in liquid
nitrogen. The positive control for the assays was taken as a
delegated sample of cremasteric muscle seen to contain
ICAM-1, this was used in each run. Negative controls were
performed using irrelevant antisera and the unbound sec-
ondary antibody from the assay alone. Scoring was carried
out by a blinded observer (KS) in a semiquantative manner
using the following grading system: 0, no stain; 1, weak
stain, scant distribution; 2, weak staining, widespread
distribution; 3, strong staining, scant distribution; and 4,
strong staining, widespread distribution.21,22
Statistical analysis. The results were expressed as the mean
or median with the 95% confidence interval (CI). Analysis
of data was performed using the one-way analysis of vari-
ance for the comparison of multiple means (one-way
ANOVA). Data were tested for normality and constant var-
iance before analysis. Significant results were analysed
using the post-hoc Tukey test. Data which were not nor-
mally distributed underwent log transformation before
analysis and these were expressed as the median (95% CI).
Significance was achieved if p < 0.05. Non-parametric data
(ICAM-1) were analysed using the Kruskal-Wallis test fol-
lowed by the Mann-Whitney U test on pairs of groups. Sig-
nificance was achieved if p < 0.05.
Results
Muscle function. Twitch and tetanic muscle contractile
function was expressed as the peak tension, in grams of
‘force’, achieved by each muscle. In the group with com-
partment syndrome muscle twitch contraction was acutely
impaired (59.9 g, 95% CI 38.5 to 81.4) compared with the
control group (202.4 g, 95% CI 154.5 to 250.3 g; one-way
ANOVA, p = 0.001, p < 0.001 versus compartment syn-
drome). This effect was blunted by pretreatment with vita-
min C (134.8 g, 95% CI, 95.5 to 174.1 g one-way ANOVA;
p = 0.001; p < 0.01 versus compartment syndrome alone;



































































































































Fig. 2a Fig. 2b
Fig. 2dFig. 2c
Effect of compartment syndrome and pretreatment with vitamin C on a) peak twitch contraction in cremasteric muscle, b) maximum tetanic contraction
in cremasteric muscle, c) MPO activity and d) on skeletal muscle oedema. The data are expressed as the mean (95% CI; * p < 0.05 versus surgical control;
† p < 0.001 versus compartment syndrome alone; ‡ p < 0.01 versus 24-hour post-surgical control (one-way ANOVA); § p < 0.01 versus 24-hour post
compartment syndrome alone (one way ANOVA). CS, compartment syndrome, VitC, vitamin C).
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twitch contraction in the compartment-syndrome group
was still significantly impaired (50.4 g; 95% CI, 30.7 to
70.1) compared with the control group (108.5; 95% CI,
78.9 to 138.2; one-way ANOVA, p = 0.006; p < 0.01 versus
compartment syndrome). In the group pretreated with vita-
min C, fast fibre function was maintained at levels above
those seen in the non-vitamin-C treated compartment-syn-
drome group (126.3 g, 95% CI, 91.2 to 161.4; one-way
ANOVA, p = 0.006; p < 0.001 versus 24 hour compartment
syndrome alone; Fig. 2a).
Tetanic muscle contraction was also significantly attenu-
ated by compartment syndrome (339.2 g, 95% CI, 269.1 to
387.9 g) when compared with the control group (618.7 g,
95% CI, 518.5 to 741.4 g; one-way ANOVA, p = 0.0002;
p < 0.001 versus compartment syndrome). As was the case
for twitch contraction, pretreatment with vitamin C main-
tained tetanic contraction (564.1, 95% CI; 418.5 to 859 g;
one-way ANOVA, p = 0.0002; p < 0.001 versus compart-
ment syndrome alone; Fig. 2b). Tetanic contraction was
reduced 24 hours after decompression of compartment syn-
drome (235.3 g, 95% CI, 170.2 to 281.3) compared with
the control group (425.4, 95% CI, 395.5 to 515; one-way
ANOVA, p = 0.0002; p < 0.001 versus 24-hour compart-
ment syndrome). Preadministration of vitamin C preserved
the function of muscle slow fibres 24 hours after injury
(431.2 g, 95% CI, 315.1 to 550.1; one-way ANOVA; p =
0.0002; p < 0.01 versus 24 hour compartment syndrome
alone; Fig. 2b).
Myeloperoxidase activity. Compartment syndrome induced
infiltration of neutrophils into muscle tissue as indicated by
a significant rise in the activity of MPO from 6.2 units/g
(95% CI, 5.1 to 6.9) in the control group to 10.6 units/g
(95% CI, 8.8 to 14.3) in the compartment-syndrome group
(one-way ANOVA p = 0.001; p < 0.0001 versus control).
This influx of leucocytes and MPO activity were reduced by
the administration of vitamin C to 8.6 units/g (95% CI; 7.7
to 9.3; one-way ANOVA; p = 0.0001; p < 0.04 versus com-
partment syndrome alone; Fig. 2c).
At 24 hours after injury, muscle MPO activity rose from
15.1 units/g (95% CI; 12.5 to 19.2) in the control group to
54.7 units/g (95% CI 34.3 to 74) in the 24-hour compart-
ment-syndrome group; one-way ANOVA, (p = 0.0001; p <
0.001 versus 24-hour control). Pre-administration of vita-
min C significantly reduced muscle MPO activity at 24
hours after compartment syndrome (29.4 units/g, 95% CI
20.6 to 41; p = 0.0001, one-way ANOVA; p < 0.05 versus
24-hour compartment syndrome alone; Fig. 2c).
Muscle oedema. This was assessed by the wet-to-dry ratio
and was higher in the compartment syndrome group (1.01,
95% CI, 0.94 to 1.08) compared with control animals
(0.75, 95% CI, 0.7 to 0.8); one-way ANOVA, p = 0.0017,
p < 0.05 versus control.
Oedema was reduced by the pre-administration of vita-
min C (0.6, 95% CI 0.32 to 0.88); one-way ANOVA p =
0.0017; p < 0.01 versus compartment syndrome alone; Fig.
2d).
After 24 hours, muscle subjected to compartment syn-
drome showed a decreased wet-to-dry ratio when com-
pared with the control group (0.71, 95% CI 0.52 to 0.89);
versus 1.36, 95% CI 1.13 to 1.6); one-way ANOVA, p =
0.0005; p < 0.01 versus 24-hour control). The vitamin-C
pretreated group showed decreased oedema versus the con-
trol group (0.74, 95% CI 0.4 to 1.1); one-way ANOVA, p
= 0.0005; p < 0.01 versus 24-hour control), but did not
differ significantly from 24-hour compartment syndrome
animals (p = 0.86; Fig. 2d).
ICAM-1 expression. In cremasteric muscle subjected to
compartment syndrome this was significantly increased
(2.5, 95% CI 1.4 to 3.94) as compared with the control
group (0.0, 95% CI, -0.15 to 1.7; Kruskal-Wallis test, p =
0.0225; Mann-Whitney U test; p = 0.028). Pre-administra-
tion of vitamin C significantly reduced muscle expression of
ICAM-1 after compartment syndrome (1.0, 95% CI, 0.12
to 1.9); Kruskal-Wallis test, p = 0.0225; Mann-Whitney U
test; p = 0.043 versus compartment syndrome (Fig. 3).
Discussion
Compartment syndrome, which is caused by excessive pres-
sure within a closed fascial tissue compartment,23 can result
from blunt or penetrating trauma, exercise or reperfusion
after ischaemia.3,24,25 Increased intracompartmental pres-
sure, either due to increased compartmental contents such
as haematoma or reduced compartmental size e.g. as a
result of a tight cast, adversely affects neuromuscular func-
tion within the compartment by decreasing the available
blood supply.26,27 Without surgical decompression, this
condition leads to ischaemia and death of the affected tis-
sue.28
The only established clinical treatment of a compartment
syndrome is surgical decompression by fasciotomy.29,30
However, despite the availability of pressure-monitoring
systems and increased awareness of the condition, compart-
ment syndrome remains a notable cause of morbidity in
clinical practice. Establishing a diagnosis of compartment



























Effect of compartment syndrome and pretreatment with vitamin C on
ICAM-1 expression (data are expressed as the median (95% CI); p < 0.05
versus surgical control; † p < 0.05 versus compartment syndrome alone
(Kruskal-Wallis test); CS, * compartment syndrome; VitC, vitamin C).
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tised or unconscious patients, and in the very young.25,31,32
In these situations, some authors recommend continuous
monitoring of pressure.5 Facilities to perform such monitor-
ing are not universally available or appropriate and a high
level of clinical suspicion is critical to making the diagnosis.
Decompression, as a treatment, is not without its compli-
cations. Fasciotomy and reperfusion result in further injury
to the muscle with an influx of activated neutrophils.8 Sub-
sequent rhabdomyolysis may result in renal failure and
acute respiratory distress syndrome.33 Even with adequate
surgical decompression, full restoration of muscle and
nerve function is not guaranteed. Microvascular dysfunc-
tion, a feature of injury to muscle caused by compartment
syndrome, is associated with the no-reflow phenomenon
and areas of persistent hypoxia within the affected muscle.8
Microvascular dysfunction and no-reflow are probably
caused initially by direct oxidant-induced endothelial
injury and oedema, and subsequently by neutrophil-medi-
ated injury.34-36 Antioxidant therapies may prevent this
endothelial dysfunction and thus allow reperfusion of all of
the muscle bed, increasing the likelihood of viability.
The return of muscle blood flow, while essential for the
survival of the tissue, initiates a cascade of inflammatory
events which cause further tissue injury. The return of
oxygen results in a massive increase in the production of
free radicals mediated by xanthine oxidase.37,38 These re-
active oxygen species, particularly H2O2 directly injure the
local endothelium,11,39 and interact with T-lymphocytes to
upregulate tumour necrosis factor-α and the production of
interleukin-8.40,41 These and other potent cytokines and
chemokines attract and activate circulating neutrophils,
thus  facilitating adhesion and transmigration of neu-
trophils into ischaemic tissue via the parallel upregulation
of adhesion molecules such as ICAM-1.40-44 Neutrophils, in
turn, release reactive oxygen species via a membrane
NADPH oxidase and MPO, injuring endothelium and tis-
sues further.45 These key steps in the response to muscle
hypoxia and the re-establishment of perfusion offer several
opportunities for therapeutic interventions.
Vitamin C has been shown to have a number of proper-
ties which suggest its potential as a therapeutic agent for the
prevention of muscle injury induced by compartment syn-
drome. Ascorbate is a critical component of the oxidant
shield in skeletal muscle, being actively accumulated by
muscle endothelium.46 Armour et al11 have shown that
ascorbate prevents H2O2-induced endothelial injury in
vitro. This scavenging effect on H2O2 which is critical to
the recruitment and adhesion of neutrophils,40,41 may
explain the reduction in the intramuscular activity of neu-
trophils as measured by MPO, seen in this experiment. This
finding of reduced neutrophil shuttling into the affected
tissue may be explained by a reduction in the expression of
adhesion molecules. In keeping with the reduction in
ICAM-1 upregulation seen in our model Lehr et al12 have
also demonstrated that administration of vitamin C reduces
oxidant-induced neutrophilic endothelial interaction in
vivo. In previous experiments from our group, vitamin C
reduced reperfusion-induced skeletal muscle and systemic
injury,13,14 presumably by reducing adhesion-molecule-
regulated transmigration of neutrophils and generation of
oxidants.
The oral biovailability of vitamin C makes it suitable for
use in clinical practice. Its bioactivity has been demonstrated
after oral and intravenous administration.12 However, con-
cerns have been expressed about long-term and high-dose
administration of ascorbate. In certain circumstances, vita-
min C may show pro-oxidant properties and generate
potentially mutagenic lesions.47 However, doses of less than
500 mg per day appear to have an antioxidant effect with-
out significant toxicity48 and achieve high intracellular con-
centration in circulating neutrophils.10,49 Multiple trials
have shown safety and anticarcinogenic properties for doses
of vitamin C of between 200 and 400 mg per day.49-51
In conclusion, there is strong experimental evidence for a
potential role for antioxidants in the reduction of injury to
skeletal muscle caused by compartment syndrome. In this
experiment vitamin C reduced ICAM-1 expression and
MPO activity in skeletal muscle after compartment syn-
drome. This reduction in the expression of adhesion
molecules and neutrophilic infiltration was accompanied
by the preservation of the contractile function of muscle
and reduction in muscle swelling. The fact that our study
assessed the effects of pretreatment with vitamin C allows
us only to comment on the potential for such a regime in
patients undergoing procedures which carry an appreciable
risk of damage to skeletal muscle caused by compartment
syndrome. Further study in this model of the effects of the
administration of vitamin C in animals after the induction
of compartment syndrome could help to ascertain whether
vitamin C has a potential therapeutic role in trauma
patients with established compartment syndrome.
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